Expression of the CCAAT/enhancer-binding proteins C/EBPα, C/EBPβ and C/EBPδ in breast cancer: Correlations with clinicopathologic parameters and cell-cycle regulatory proteins

Breast Cancer Research and Treatment

Volumn 79, Issue 2, 2003, Pages 175-185

  Milde Langosch, Karin ^a   Löning, Thomas ^a   Bamberger, Ana Maria ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Breast cancer; C EBP family; C EBP ; C EBP ; C EBP ; LAP; LIP; Western blots

Indexed keywords

CCAAT BINDING FACTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CYCLIN E; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LIVER ENRICHED TRANSCRIPTIONAL ACTIVATING PROTEIN 1; LIVER ENRICHED TRANSCRIPTIONAL ACTIVATING PROTEIN 2; LIVER ENRICHED TRANSCRIPTIONAL INHIBITORY PROTEIN; PROGESTERONE RECEPTOR; PROTEIN P16; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CELL; CANCER GRADING; CELL DIFFERENTIATION; CELL PROLIFERATION; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; STATISTICS; TRANSCRIPTION FACTORS;

EID: 0038018480     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023929504884     Document Type: Article

References (29)

1. Lekstrom-Himes J, Xanthopoulos KG: Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273: 28545-28548, 1998
2. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL: Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Gene Dev 3: 1146-1156, 1989
3. Osada S, Yamamoto H, Nishihara T, Imagawa M: DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 271: 3891-3896, 1996
4. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG: Dominant-negative mutations of CEBPα, encoding CCAAT/enhancer binding protein-alpha/C/EBPalpha), in acute myeloid leukemia. Nat Genet 27: 263-270, 2001
5. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Gene Dev 5: 1538-1552, 1991
6. Halmos B, Huettner C, Kocher O, Ferenczi K, Karp DD, Tenen DG: Down-regulation and antiproliferative role of c/EBPα in lung cancer. Cancer Res 62: 528-534, 2002
7. Robinson GW, Johnson PF. Hennighausen L, Sterneck E: The C/EBPβ transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Gene Dev 12: 1907-1916, 1998
8. Welm AL, Timchenko NA, Darlington GJ: C/EBPα regulates generation of C/EBPβ isoforms through activation of specific proteolytic cleavage. Mol Cell Biol 19: 1695-1704, 1999
9. Xiong W, Hsieh C-C, Kurtz AJ, Rabek JP, Papaconstantinou J: Regulation of CCAAT/enhancer-binding protein-β isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Res 29: 3087-3098, 2001
10. O'Rourke J, Yuan R, DeWille J: CCAAT/enhancer binding protein-δ (C/EBP-δ) is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 272: 6291-6296, 1997
11. Raught B, Liao WS, Rosen JM: Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol 9: 1223-1232, 1995
12. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ, Rosen JM: C/EBPβ, but not c/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Gene Dev 12: 1917-1928, 1998
13. Zahnow CA, Younes P, Laucirica R, Rosen JM: Overexpression of C/EBPβ-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer I 89: 1887-1891, 1997
14. Milde-Langosch K, Bamberger AM, Methner C, Rieck G, Löning T: Expression of cell cycle regulatory proteins Rb, p16/MTS1, p27/Kip1, p21/Waf1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members. Int J Cancer 87: 468-472, 2000
15. Milde-Langosch K, Goemann C. Methner C, Rieck G, Bamberger AM, Löning T: Expression of Rb2/p130 in breast and endometrial cancer: correlations with steroid hormone receptor status and Rb expression. Brit J Cancer 85: 564-551, 2001
16. Bamberger A-M, Methner C, Lisboa BW, Städtler C, Schulte HM, Löning T, Milde-Langosch K: Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive phenotype. Int J Cancer 84: 553-558, 1999
17. Christian M, Pohnke Y, Kempf R, Gellersen B, Brosens JJ: Functional association of PR and CCAAT/enhancer-binding protein β isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol Endocrinol 16: 141-154, 2002
18. Slomiany BA, D'Arigo KL, Kelly MM, Kurtz DT: C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol 20: 5986-5997, 2000
19. Charles A, Tang X, Crouch E, Brody JS, Xiao ZX: Retinoblastoma protein complexes with C/EBP proteins and activates C/EBP-mediated transcription. J Cell Biochem 83: 414-425, 2001
20. Dearth LR, Hutt J, Sattler A, Giglotti A, DeVille J: Expression and function of CCAAT/enhancer binding protein beta (C/EBPβ) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells. J Cell Biochem 82: 357-370, 2001
21. Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM: C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol 14: 359-368, 2000
22. Timchenko NA, Harris TE, Wilde M, Bilyeu TA, Burgess-Beusse BL, Finegold MJ, Darlington GJ: CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol 17: 7353-7361, 1997
23. Emig R, Magener A, Ehemann V, Meyer A, Stilgenbauer F, Volkmann M, Wallwiener D, Sinn H-P: Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation. Brit J Cancer 78: 1661-1668, 1998
24. Milde-Langosch K, Bamberger A-M, Rieck G, Kelp B, Löning T: Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Tr 67: 61-70, 2001
25. Billiard J, Umayahara Y, Wiren K, Centrella M, McCarthy TL, Rotwein P: Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts. J Biol Chem 276: 15354-15361, 2001
26. Zahnow CA, Cardiff RD, Laucirica R, Medina D, Rosen JM: A role for CCAAT/enhancer-binding protein-β-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res 61: 261-269, 2001
27. Dublin EA, Patel NK, Gillett CE, Smith P, Peters G, Barnes DM: Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histological parameters. Int J Cancer 79: 71-75, 1998
28. INK4a messenger RNA is a marker of poor prognosis. Clin Cancer Res 6: 2777-2787, 2000
29. Rask K, Thorn M, Ponten F, Kraaz W, Sundfeldt K, Hedin L, Enerback S: Increased expression of the transcription factor CCAAT/enhancer binding protein-beta (c/EBPβ) and C/EBPζ (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 86: 337-343, 2000